Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Genomics02:02

Genomics

39.6K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Content-based image retrieval for Lung Nodule Classification Using Texture Features and Learned Distance Metric.

Journal of medical systems·2017
Same author

[Association between the ALK Gene Status and the Efficacy of First-line 
Pemetrexed Chemotherapy in Patients with Advanced Lung Adenocarcinoma].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2017
Same author

3D hole-transporting materials based on coplanar quinolizino acridine for highly efficient perovskite solar cells.

Chemical science·2017
Same author

ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.

Journal of Cancer·2017
Same author

The collective influence of 1, 25-dihydroxyvitamin D<sub>3</sub> with physiological fluid shear stress on osteoblasts.

Steroids·2017
Same author

A new analytical model for the changes of vascular endothelial growth factor in ischemic diseases.

Medical hypotheses·2017
Same journal

A Multi-Modal Framework for Phage-Host Interaction Prediction Using Multi-View Contrastive Learning.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Decoding Gene-Disease Associations with Computational Methods: A Survey.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

A Competitive Coevolution-based Cancer Driver Pathway Identification Algorithm for Maximizing Coverage, Mutual Exclusivity, and Subnet Importance.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Prediction of GO Terms Based on Partitioning PPI Networks into Highly Connected Components.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems.

IEEE transactions on computational biology and bioinformatics·2026
Same journal

Parameter Efficient Deep Learning Models for Multi-Target Binding Affinity and hERG Cardiotoxicity Prediction.

IEEE transactions on computational biology and bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K

Survival-Informed Multi-Omics Kernel Fusion for Cancer Subtyping.

Xiaojian Ding, Pengcheng Shi, Xin Wang

    IEEE Transactions on Computational Biology and Bioinformatics
    |January 6, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Survival-Informed Multi-omics Kernel Fusion (SIMKF) identifies distinct cancer subtypes using multi-omics data. This novel framework improves cancer subtyping for precision oncology and personalized therapy.

    More Related Videos

    Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments
    03:49

    Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

    Published on: October 13, 2023

    1.7K
    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    9.4K

    Related Experiment Videos

    Last Updated: Jan 13, 2026

    Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
    07:47

    Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

    Published on: September 15, 2023

    2.1K
    Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments
    03:49

    Author Spotlight: Enhancing Nuclei Isolation for Multiome Sequencing in Challenging Tumor Microenvironments

    Published on: October 13, 2023

    1.7K
    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
    07:41

    Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

    Published on: May 17, 2019

    9.4K

    Area of Science:

    • Computational biology
    • Bioinformatics
    • Genomics

    Background:

    • Cancer molecular heterogeneity complicates precise subtyping and personalized treatment.
    • Existing multi-omics integration methods often lack clinical relevance and kernel redundancy, limiting prognostic utility.

    Purpose of the Study:

    • To introduce Survival-Informed Multi-omics Kernel Fusion (SIMKF), a framework designed to uncover clinically distinct cancer subtypes.
    • To address limitations in current multi-omics integration by incorporating survival information and improving prognostic accuracy.

    Main Methods:

    • SIMKF framework combines survival-guided kernel selection with distribution-aware fusion.
    • Utilizes adaptive weighting based on maximum mean discrepancy and spectral clustering.
    • Integrates survival information with multi-omics data for enhanced cancer subtyping.

    Main Results:

    • SIMKF significantly outperforms existing techniques across five TCGA cancer datasets.
    • Identified five distinct breast cancer subtypes with significant survival differences.
    • Revealed a nonlinear relationship between methylation levels and survival outcomes in breast cancer.

    Conclusions:

    • SIMKF provides an automated, tuning-free tool for precision oncology.
    • The framework uncovers prognostic biological mechanisms and translates into clinically applicable subtyping models.
    • SIMKF enhances the prognostic utility of multi-omics data for personalized cancer therapy.